Is This Under-the-Radar COVID Stock the Next Moderna?

Is This Under-the-Radar COVID Stock the Next Moderna?
Adria Cimino, The Motley Fool
·4 min read

Gritstone Oncology (NASDAQ: GRTS) started the week as a little-known player in the coronavirus vaccine space. Its shares -- and market capitalization -- soared. Gritstone said its vaccine candidate targets that very problem.